Patents 198show all

  • 112
    A61K - Preparations for medical, dental, or toilet purposes
  • 26
    C07C - Acyclic or carbocyclic compounds
  • 25
    C07D - Heterocyclic compounds
  • 24
    C07F - Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
  • 17
    Y02A - Technologies for adaptation to climate change
  • 7
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 7
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 4
    C07H - Sugars
  • 3
    Y02P - Climate change mitigation technologies in the production or processing of goods
  • 1
    A61N - Electrotherapy

Clinical Trials 7show all

3Phase 2/Phase 32N/A1Phase 1/Phase 21Phase 2

SEC Filings show all


267
8-K

72
10-Q

23
10-K

5
D

1
S-1

Contact Information

Boston, MA
United States

SEC Form D Funding Events

DateOfferedSoldType
2010-03-26$7,500,000$7,500,000Equity, Option to Acquire
2008-11-04Unknown Unknown Other (Paper Filing)

Key Executives

  • Peter J. Langecker
    Executive Officer
  • William N. Shiebler
    Director
  • James B. Murphy
    Executive Officer
  • Roy H. Fickling
    Director
  • William D. Schwieterman
    Director
  • Mark Kessel
    Director
  • Alastair J.j. Wood
    Director
  • David Chaplin
    Executive Officer, Director